Molecular techniques for the investigation of meningococcal disease epidemiology

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 18, Issue 2, 2001, Pages 119-134

  Maiden, Martin C ^a   Frosch, Matthias ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Meningococcal disease; Molecular diagnosis; Molecular epidemiology; Neisseria meningitidis; Population biology

Indexed keywords

BIODIVERSITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; INFECTION CONTROL; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW;

ANTIGENS, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PORINS; VARIATION (GENETICS);

EID: 0034931798     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:18:2:119     Document Type: Review

References (145)

1. Meningococcal disease: Still with us
2. Neisseria meningitidis: Clinical aspects
3. Interaction mechanisms of encapsulated meningococci with eucaryotic cells: What does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis?
4. The lipooligosaccharides of pathogenic gram-negative bacteria
5. Pathogenesis of meningococcal infections
6. Clinical aspects of meningococcal disease
7. Clinical spectrum of meningococcal disease
8. Management of early meningococcal disease
9. Early treatment with parenteral antibiotic in meningococcal disease
10. Polymerase chain reaction for diagnosis of meningococcal infection
11. 875 Cases of bacterial meningitis: Diagnostic procedures and the impact of preadmission antibiotic: Part III of a three-part series
12. Meningococcal infections in England and Wales
13. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease
14. Polymerase chain reaction of peripheral blood for the diagnosis of meningococcal disease
15. Global epidemiology of meningococcal disease
16. Population genetics and global epidemiology of the human pathogen Neisseria meningitidis
17. Cerebrospinal meningitis epidemics
18. Global epidemiology of meningococcal disease
19. Human immunity to the meningococcus IV. Immunogenicity of group A and group C meningococcal polysaccharides
20. A trial of a group A plus group C meningococcal polysaccharide- protein conjugate vaccine in African infants
21. Meningococcal vaccines: Past, present, and future
22. Serological relationships among meningococci
23. Development of meningococcal serogroups
24. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens
25. Development of meningococcal serotyping
26. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes
27. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies
28. Meningococcal typing
29. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern
30. Molecular epidemiology of epidemic bacterial meningitis
31. Cell-free biosynthesis of the O-acetylated N-acetylneuraminic acid capsular polysaccharide of group C meningococci
32. Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide
33. Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance
34. Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1
35. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents
36. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1
37. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide
38. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections
39. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: Isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci
40. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): Correlation with bacterial invasion and the outbreak of meningococcal disease
41. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element
42. Capsule switching of Neisseria meningitidis
43. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B
44. Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B
45. Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules
46. Characterization of the gene cassette required for biosynthesis of the (alpha1→6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis
47. Phospholipid substitution of capsular polysaccharides and mechanisms of capsule formation in Neisseria meningitidis
48. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis
49. Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides
50. Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression
51. The class 1 outer membrane protein of Neisseria meningitidis: Gene sequence and structural and immunological similarities to gonococcal porins
52. Deduced amino acid sequences of class 1 protein PorA from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity
53. Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis
54. Molecular analysis of the serotyping antigens of Neisseria meningitidis
55. Identification of Variable Region Differences in Neisseria meningitidis Class 3 Protein Sequences Among Five Group B Serotypes
56. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design
57. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998
58. Structural analysis of the variation in the major outer membrane proteins of Neisseria meningitidis and related species
59. Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins of pathogenic and non-pathogenic Neisseria species
60. Topology of outer membrane porins in pathogenic Neisseria spp
61. Structural and evolutionary inference from molecular variation in Neisseria porins
62. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA
63. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies
64. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies
65. Monoclonal antibody recognition of members of the P1. 10 variable region family: Implications for serological typing and vaccine design
66. The porA gene in serogroup A meningococci: Evolutionary stability and mechanism of genetic variation
67. Point mutation in meningococcal porA gene associated with increased endemic disease
68. Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins
69. Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter
70. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation
71. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system
72. Molecular variation of meningococcal serotype 4 antigen genes
73. Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis
74. Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques
75. Amplification of the meningococcal porB gene for non-culture serotype characterisation
76. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics
77. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease
78. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms
79. A multilocus sequence typing scheme for Streptococcus pneumoniae identification of clones associated with serious invasive disease
80. A multi locus sequence typing system for Campylobacter jejuni
81. Parallel evolution of virulence in pathogenic Escherichia coli
82. Multilocus sequence typing for the characterization of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) clones of Staphylococcus aureus
83. Rifampicin resistance in Neisseria meningitidis: Evidence from a study of sibling strains, description of new mutations and notes on population genetics
84. Sulphonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species
85. Penicillin-binding protein 2 genes of non-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae
86. Transformational Exchanges in the Dihydropterate Synthase Gene of Neisseria meningitidis: A novel mechanism for the Acquisition of Sulfonamide Resistance
87. Cloning and characteriztion of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis
88. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species
89. Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: Natural events and laboratory simulation
90. Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria
91. Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis
92. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis
93. Epidemiological evaluation of Neisseria meningitidis serogroup B by pulsed-field gel electrophoresis
94. Applications of restriction endonuclease fingerprinting of chromosomal DNA of Neisseria meningitidis
95. DNA fingerprinting in the epidemiology of African serogroup A Neisseria meningitidis
96. Phylogenetic and epidemiological analysis of Neisseria meningitidis using DNA probes
97. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers
98. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
99. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491
100. Rapid diagnosis of bacterial meningitis by a seminested PCR strategy
101. Dangers of lumbar puncture
102. A rapid and sensitive PCR strategy employed for amplification and sequencing of porA from a single colony-forming unit of Neisseria meningitidis
103. Intra- and extracellular expression of an scFv antibody fragment in E. coli: Effect of bacterial strains and pathway engineering using GroES/L chaperonins
104. Therapeutic human antibodies derived from PCR amplification of B-cell variable regions
105. On the evolutionary descent of organisms and organelles: A global phylogeny based on a highly conserved structural core in small subunit ribosomal RNA
106. Detailed analysis of the higher- order structure of 16S-like ribosomal ribonucleic acids
107. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy
108. One-step heminested PCR for amplification of Neisseria meningitidis DNA in cerebrospinal fluid
109. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples
110. Amplification of rDNA loci to detect and type Neisseria meningitidis and other eubacteria
111. PCR Diagnosis
112. Outbreak management
113. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA
114. siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections
115. Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA
116. Polymerase chain reaction for case ascertainment of meningococcal meningitis: Application to the cerebrospinal fluids collected in the course of the Norwegian serogroup B protection trial
117. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction
118. Identification and characterization of a novel insertion sequence, IS1106, downstream of the por gene in B15 Neisseria meningitidis
119. The adaptation of the IS1106 PCR to a PCR ELISA format for the diagnosis of meningococcal infection
120. False positive diagnosis of meningococcal infection by the IS1106 PCR ELISA
121. Molecular population genetic analysis of emerged bacterial pathogens: Selected insights
122. High-throughput sequencing in the population analysis of bacterial pathogens
123. The relative contribution of recombination and mutation to the divergence of clones of Neisseria meningitidis
124. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis
125. Genetic diversity and structure in Escherichia coli populations
126. Bacterial population genetics, evolution and epidemiology
127. How clonal are bacteria?
128. Localized sex in bacteria
129. Population genetics of a transformable bacterium: The influence of horizontal genetical exchange on the biology of Neisseria meningitidis
130. Sequence diversity within the argF, fbp and recA genes of natural isolates of Neisseria meningitidis: Interspecies recombination within the argF gene
131. Interspecies recombination in nature: A meningococcus that has acquired a gonococcal PIB porin
132. Do bacteria have population genetics?
133. Carried meningococci in the Czech Republic: A diverse recombining population
134. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers
135. The maintenance of strain structure in populations of recombining infectious agents
136. Vaccines for prevention of meningococcal disease
137. Immunologic response of man to group B meningococcal polysaccharide vaccines
138. Antigenic similarities between brain components and bacteria causing meningitis: Implications for vaccine development and pathogenesis
139. Meningococcal disease falls in vaccine recipients
140. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
141. Vaccine against group B Neisseria meningitidis: Protection trial and mass vaccination results in Cuba
142. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
143. Meningococcal conjugate vaccines: New opportunities and new challenges